Navigation Links
Patient-Focused Drug Delivery to be Presented by Catalent at PODD
Date:10/17/2018

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that Cornell Stamoran, Ph.D., Vice President of Strategy and co-chair of Catalent’s Applied Drug Delivery Institute, will present at the annual Partnership Opportunities in Drug Delivery (PODD) meeting at the Westin Copley Place, Boston on Oct. 17 – 18, 2018.

On Thursday, Oct. 18 at 9:10 a.m., in a session titled “The Pediatric Patient Perspective of Drug Delivery and Connected Health,” Dr. Stamoran will interview Alex Rinaudo, a patient advocate, about his personal experience caring for his son, who has type 1 diabetes mellitus. The discussion will cover the family’s daily routine, how chronic conditions require constant care by a range of people, and how treatments evolve as pediatric patients get older.

Later that day, at 12:30 p.m., Dr. Stamoran will moderate a Luncheon Roundtable titled, “Patient-Focused Drug Delivery.” Attendees will share their experiences and insights on how the pharmaceutical industry can improve the lives and outcomes of patients through application of drug delivery technologies.

Dr. Stamoran leads Catalent’s strategic planning, market intelligence and government affairs efforts. He also serves as Co-Chair and Director of Catalent’s Applied Drug Delivery Institute (http://www.drugdeliveryinstitute.com). Dr. Stamoran has spent nearly 30 years engaged with the health care industry, including more than 25 years in advanced drug and biologic delivery and outsourcing.

For more information visit the event landing page.

To arrange a meeting with Dr. Stamoran at the event, contact Richard Kerns at NEPR - richard(at)nepr.eu

About the Catalent Applied Drug Delivery Institute
Catalent’s Applied Drug Delivery Institute was founded to serve as a link between industry and academia, advance education and training in drug delivery in academia and the industry, accelerate adoption of applied drug delivery technologies to develop better treatments, and foster industry collaboration on major issues pertaining to drug development, formulation, and delivery. It is pursuing a multi-tiered approach of research, strategic counsel, and educational programs to advance the adoption of emerging technologies.
For more details on the Catalent Institute, visit http://www.drugdeliveryinstitute.com and follow the Catalent Institute on Twitter: @DrugDeliveryIns

About Catalent
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs over 11,000 people, including over 1,800 scientists, at more than 30 facilities across five continents, and in fiscal 2018 generated approximately $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com.

More products. Better treatments. Reliably supplied.™

Read the full story at https://www.prweb.com/releases/patient_focused_drug_delivery_to_be_presented_by_catalent_at_podd/prweb15847577.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology technology :

1. MedAvante Names Leader for Patient-Focused eSolutions
2. Point-of-Delivery Drug. Reconstitution Systems Markets, Strategies and Prospects
3. Express Genes by Eurofins MWG Operon Offers 4 Day Delivery of Synthetic Genes
4. Cardiovascular Drug Delivery - Technologies, Markets and Companies - 2013 Report
5. Will Safety Concerns Slow Nanotechnology Drug Delivery Market Growth? Forecasts Predict 84.79% Growth in US, 73.97% Globally through 2016
6. North American Injectable Drug Delivery Market worth $16.6 Billion by 2017
7. Patheon Exhibits and Presents at the 2013 IQPC Global Formulation and Drug Delivery Summit
8. Surefire Medical Launches Next Generation Infusion System ST-LT and Specialty Catheters at SIR - Maximizing Targeted Delivery of Embolics Without Reflux
9. Drug Delivery Technology Market worth $224.2 Billion By 2017
10. mPhase Technologies, Inc. Commencing Discussions with Major European Drug Company for Drug Delivery System
11. Global Transfection (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) Technologies Market (2012 - 2017)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2020)... ... March 26, 2020 , ... iFirst Medical Technologies, Inc., a leader ... nasal swab test. , "COVID-19 poses a grave danger to public health here in ... iFirst are compelled to act. Broad-based testing and on-the-spot results promise to slow the ...
(Date:3/19/2020)... ... March 18, 2020 , ... Family counsellors, marriage/couples therapists, ... rapid insight into their perceptions of events. Imagine if a couple’s counsellor could ... they could measure the level of engagement of each individual in the therapeutic ...
(Date:3/12/2020)... ... 2020 , ... With the beginning of 2020, Park Systems, ... in Europe by inaugurating a new scientific facility for academic and industrial research ... Center Europe took place Tuesday, February 18, 2020, gathering customers, collaborators and business ...
(Date:3/10/2020)... ... March 10, 2020 , ... ... biopharmaceutical engineering firm, is pleased to announce the addition of Carson Dickey ... device qualification and validation in the biopharmaceutical cold chain. He provides design ...
Breaking Biology Technology:
(Date:3/11/2020)... ... March 11, 2020 , ... Polysense Technologies ... smart human body temperature infrared touch-free monitoring product family, a standalone thermal meter ... supporting flexible wireless uplink for cloud connectivity such as NB-IoT, Wi-Fi, LoRaWAN, and ...
(Date:3/5/2020)... ... March 05, 2020 , ... Patients in need of new teeth after ... Nickelice Brand of Dental Implants of Ocala. Same-day dental implants allow patients ... smile in just one day. This treatment utilizes advanced technology and Dr. Brand’s unique ...
(Date:3/4/2020)... ... March 04, 2020 , ... VGXI, Inc., a uniquely specialized ... nominated as a finalist in the category of Best Contract Manufacturing Organization for ... manufacturing of a DNA vaccine against the novel coronavirus, COVID-19, under a CEPI ...
Breaking Biology News(10 mins):